Lilly Eli and Co News - LLY

/C O R R E C T I O N -- Eli Lilly and Company/

In the news release, FDA Approves Expanded Use of Lilly's (NYSE: LLY) FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid...

FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporos

First and only FDA-approved anabolic agent in the U.S. now indicated to treat the leading type of secondary osteoporosis INDIANAPOLIS, July 23...

National Report Ranks Oklahoma as a Top State for Mental Health Services

Ranking Featured Oklahoma's Innovative SoonerPSYCH Program OKLAHOMA CITY, July 21 /PRNewswire-FirstCall/ -- Over the past three years, Oklahoma...

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass., July 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc., (NASDAQ:AMLN), Eli Lilly and...

Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement

INDIANAPOLIS, July 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE:LLY) will announce its financial results for the second quarter of...

Top 10 Tips for Staying Healthy When Money is Tight

Leading health care organizations help Ohioans live healthier lives INDIANAPOLIS, July 6 /PRNewswire-FirstCall/ -- Several area health care...

Lilly Declares Third-Quarter Dividend

INDIANAPOLIS, June 22 /PRNewswire-FirstCall/ -- The board of directors of Eli Lilly and Company (NYSE:LLY) today declared a dividend for the...

Eli Lilly and Company Announces New Drug Discovery Initiative

Goal is to foster open collaboration between Lilly and global laboratory researchers INDIANAPOLIS, June 15 /PRNewswire-FirstCall/ -- Alzheimer's...

FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications

ADELPHI, Md., June 10 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC...

Successful Disease Management Programs Can Play Role in Health Care Reform

Medicaid Pharmacy Management Program Improves Patient Care While Saving Eight States Almost $95 Million INDIANAPOLIS, June 8...

Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes

NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) announced today new, positive Phase II study results of...

Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients

ORLANDO, Fla., May 31 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced today that Phase III trial data showed the addition of Lilly's...

Trade Alerts on Stocks in the Spotlight: BKS, HRL, PDCO, DUK, SMRT, LLY; Issued by Beacon Equity

DALLAS, May 21 /PRNewswire/ -- BeaconEquity.com announces availability of stock alerts on companies making ground in today's market, issuing...

Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management

Collaboration combines insulin expertise of Lilly with Medtronic delivery and glucose sensing leadership INDIANAPOLIS and MINNEAPOLIS, May 19...

Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting

Three-year data show olanzapine LAI safety findings consistent with oral olanzapine except for injection-related events INDIANAPOLIS, May 18...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Lilly Eli and Co (LLY)

Empower your portfolio: Real-time discussions and actionable trading ideas.

LLY News

/C O R R E C T I O N -- Eli Lilly and Company/

FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporos

National Report Ranks Oklahoma as a Top State for Mental Health Services

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement

Top 10 Tips for Staying Healthy When Money is Tight

Lilly Declares Third-Quarter Dividend

Eli Lilly and Company Announces New Drug Discovery Initiative

FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications

Successful Disease Management Programs Can Play Role in Health Care Reform

Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes

Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients

Trade Alerts on Stocks in the Spotlight: BKS, HRL, PDCO, DUK, SMRT, LLY; Issued by Beacon Equity

Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management

Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting

LLY Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Lilly Eli and Co (LLY) News

Lilly Eli and Co (LLY)

Empower your portfolio: Real-time discussions and actionable trading ideas.

LLY News

/C O R R E C T I O N -- Eli Lilly and Company/

FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporos

National Report Ranks Oklahoma as a Top State for Mental Health Services

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement

Top 10 Tips for Staying Healthy When Money is Tight

Lilly Declares Third-Quarter Dividend

Eli Lilly and Company Announces New Drug Discovery Initiative

FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications

Successful Disease Management Programs Can Play Role in Health Care Reform

Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes

Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients

Trade Alerts on Stocks in the Spotlight: BKS, HRL, PDCO, DUK, SMRT, LLY; Issued by Beacon Equity

Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management

Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting

LLY Discussion

Your Recent History